Top Tweets for #Keytruda
Der US-Pharmakonzern #Merck (Anteil im antea-Fonds 0,1%) erreicht einen Therapiedurchbruch bei der Behandlung von Lungenkrebs. Die Kombination aus den Präparaten #Calderasib und #Keytruda lassen hoffen und den Kurs der Aktie um 4,85% steigen https://t.co/RpRi9lzgAu
Bestverkochte #kankermedicijnen van 2025 - #Keytruda loopt mit $ 31,7 miljard mijlenver voorop. Top 10-ranglijst met omzet vind je hier:
https://t.co/w2L1RabvYo
#nieuws #media #kanker #OncoAlert #Pharma #Biotech #Gezondheidszorg #Kankeronderzoek #ASCO26 #ASCO2026
Die meistverkauften #Krebsmedikamente des Jahres 2025 - #Keytruda führt das Feld mit 31,7 Mrd. $ mit großem Vorsprung an. Das Top-10-Ranking mit Umsätzen finden Sie hier:
https://t.co/w2L1RabvYo
#Nachrichten #Medien #Krebs #OncoAlert #Gesundheitswesen #Krebsforschung #ASCO26
Best selling #cancer drugs of 2025- #Keytruda at $31.7B leads the field by a huge margin. Top 10 ranking with revenues, indications, and growth drivers here
https://t.co/w2L1RabvYo
#Oncology #OncoAlert #Pharma #Biotech #Healthcare #CancerResearch #ASCO26 #ASCO2026
Agilent wins FDA backing to move more Keytruda-linked PD-L1 testing onto Dako Omnis https://t.co/7VjjbZ6OJX Find out how Agilent’s expanded PD-L1 test approval could change automated cancer diagnostics and oncology lab workflows. #Agilent #PDL1 #DakoOmnis #Keytruda #Merck #CompanionDiagnostics #Oncology #Immunotherapy #FDAApproval #Pathology @Agilent
🧬#ASCO2026 アップデート | 個別化がんワクチンが引き続き有望な成果を示す
5年間の追跡結果において、#IntismeranAutogene（mRNA-4157/V940）＋ #KEYTRUDA（#ペムブロリズマブ）は以下を達成：
🔹再発または死亡リスクを49%低減
🔹遠隔転移または死亡リスクを59%低減
🔹全生存期間（OS）改善の有望な傾向を確認
🚀個別化ネオアンチゲンワクチンは、がん免疫療法の次なる柱となるのでしょうか？
🔗詳細はこちら：https://t.co/9bVFxkzbey
#メラノーマ #がんワクチン #mRNA #免疫療法 #腫瘍学 #バイオテック #ASCO #ASCO26
🧬#ASCO2026 Update | Personalized cancer vaccines continue to deliver
At 5 years of follow-up, #Intismeran autogene (mRNA-4157/V940) + #KEYTRUDA (#pembrolizumab) demonstrated:
🔹49% reduction in risk of recurrence or death
🔹59% reduction in risk of distant metastasis or death
🔹Encouraging trend toward improved overall survival
🚀Could individualized neoantigen vaccines become the next pillar of cancer immunotherapy?
🔗Read more: https://t.co/PEVBr3KL6X
#Melanoma #CancerVaccine #mRNA #Immunotherapy #Oncology #Biotech #ASCO #ASCO26
$nwbo @alphavestcap
@andrewcaravello·Jan 23Show more#KRAS Stack and #KEYTRUDA Need Dendritic Cell Instruction in #PanCAN 📷 TLDR Dr. Elizabeth Jaffee’s title is a structural assertion, not a marketing one. The cancer🧬 The Cancer Vaccine Era Has Arrived: How Jaffee’s Map Converges with $NWBO #Murcidencel #DCVax, and Why$MRKQuoted_stock@d_stock07734·Jan 21$NWBO World-Leading Tumor Immunologists Nina Bhardwaj and Elizabeth Jaffee Appointed Associate Directors of the Cancer Research Institute Scientific Advisory Council https://t.co/bbyEtTeHqI Abstract 3102A: Analysis of spatial relationships between infiltrating immune cellsAndrew Caravello, DO@andrewcaravelloplease explain how this post describes an immune bypass in pancreatic cancer rather than a traditional immune stimulant. Use DCVax as the reference architecture and contrast it with GVAX. Write for a scientifically literate audience. Frame the conclusion in terms of systems engineering or control theory applied to immunology.@grok Views10:15 AM · Jan 23, 2026·195Grok📷@grok·Jan 23The thread highlights an immune bypass strategy in PDAC by addressing dendritic cell (DC) dysfunction in the suppressive tumor microenvironment (TME), where endogenous DCs often fail to mature properly or produce IL-12, leading to weak T-cell priming. DCVax serves as the reference: it bypasses TME suppression via ex vivo DC maturation and tumor lysate loading, ensuring controlled, Type 1-polarized instruction for robust, antigen-specific T-cell responses. This creates high-quality, persistent killers that infiltrate and remodel the TME. In contrast, GVAX relies on in situ recruitment of endogenous DCs via GM-CSF-secreting tumor cells, which can be inconsistent in PDAC's myeloid-dominant TME, often yielding immature TLS or limited durability without additional agonists. From a systems engineering perspective, PDAC immunity is a feedback control system with faulty sensors (impaired endogenous DCs). DCVax acts as an external controller, injecting precise setpoints (mature DCs) to stabilize output (durable T-cell memory), while GVAX attempts gain amplification on noisy endogenous loops, risking instability.
@SellasLife $SLS $MRK
@Merck & Co.: Evaluating #GPS in combination with #Keytruda for various #cancer indications. @MSKCancerCenter MSK: Developing WT1 peptide vaccine technology. @GenFleet Therapeutics: Partnership for development & commercialization of the CDK9 inhibitor.
$SLS #Stock Rises Overnight: Traders Rally Behind @JimCramer's '#Two_Thumbs_Up' Call Ahead Of Key #AML_Readout. @SellasLife Sciences (SLS) climbed 2% in overnight trading heading into Friday after @CNBC's Jim Cramer gave the #biotech a bullish endorsement
@SellasLife $SLS $MRK
@Merck & Co.: Evaluating #GPS in combination with #Keytruda for various #cancer indications. @MSKCancerCenter MSK: Developing WT1 peptide vaccine technology. @GenFleet Therapeutics: Partnership for development & commercialization of the CDK9 inhibitor.
One of the great gifts of short sellers:
they keep offering me discounted Moderna shares.
Thank you!
#Keytruda #Intismeran #Melanoma $mrna
cc @EricTopol @RobertoBurioni
Moderna (MRNA) and Merck (MRK) cancer vaccine sustains benefit at five years, but investors stay cautious https://t.co/AoqzHg3qtK $MRNA $MRK #MRNA #MRK #Moderna #Merck #CancerVaccine #mRNA #Keytruda #Immunotherapy #Oncology #Biotech
O mercado de oncologia continua a evoluir! O #Keytruda lidera as vendas globais em 2025 com US$ 31,7 bilhões. Confira a lista completa dos 10 medicamentos contra o câncer que impulsionam a receita
https://t.co/Fp2fChY4T5
#Oncologia #Farma #PesquisaCancer #Saúde #Biotech
Le marché de l'oncologie continue d'évoluer ! #Keytruda domine les ventes mondiales en 2025 avec 31,7 milliards de dollars. Découvrez le classement complet des 10 #médicaments anticancéreux générant le plus de revenus
https://t.co/Fp2fChY4T5
#Oncologie #Santé #Biotech #France
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.6M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers